SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Ask Michael Burke

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Knighty Tin who wrote (96731)7/18/2002 8:15:08 PM
From: ild  Read Replies (1) of 132070
 
Press Release
SOURCE: Vasomedical, Inc.
New Data Show Significant Reduction in Angina Severity Maintained At Two Years in Heart Failure Patients Using Vasomedical's EECP Therapy
More Than 75 Percent of Patients in Study Do Not Experience Worsening of Heart Failure Symptoms During Two-Year Follow-Up Period
biz.yahoo.com

EDIT: The only thing which is missing with VASO is massive insider buying. I guess they are in a quiet period and can't buy (or sell).
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext